Search
- All
- News
- Opinion
- Commentary
- Media Miss
The White House released President Joe Biden’s next plans to reassure concerned Democrats after last week’s debate. And July 4 holiday travelers are expected to break records on the road amid soaring temperatures. These stories and more highlight The Morning Rundown for Wednesday, July 3, 2024. Biden looks to solidify support from Democrats after debate President Joe Biden…
Dozens of Jeffrey Epstein court documents unsealed, naming high-profile figures: The Morning Rundown, Jan. 4, 2024
Dozens of court documents related to Jeffrey Epstein are unsealed to the public. And the Justice Department is suing Texas over its new immigration law. These stories and more highlight The Morning Rundown for Thursday, Jan. 4, 2024. Previously sealed Jeffrey Epstein court documents released Hundreds of pages of previously sealed court documents related to…
The Centers for Disease Control and Prevention has a national vaccine safety surveillance program that monitors the safety of vaccines called the Vaccine Adverse Event Reporting System (VAERS). The program helps to detect unusual or unexpected reporting patterns of adverse events from vaccines. However, a British Medical Journal report found that VAERS is “overwhelmed,” raising concerns that the…
On Wednesday, Nov. 8, the Food and Drug Administration approved Zepbound, a new weight loss drug by the pharmaceutical company Eli Lilly. It’s the latest type 2 diabetes drug designed to improve blood sugar control that has been found to help with weight loss. In light of increasing rates of both obesity and overweight in…
The big takeaways from the 3rd Republican primary presidential debate: The Morning Rundown, Nov. 9, 2023
Five Republican candidates took the stage Wednesday night, Nov. 8, making their case to be the next president in the third GOP primary debate. And Hollywood actors reach a tentative deal with the studios to put an end to the nearly four-month strike. These stories and more highlight The Morning Rundown for Thursday, Nov. 9. Recapping…
The Food and Drug Administration has warned consumers to stop using certain over-the-counter eye drops that could cause eye infections. The FDA warning covers 27 eye drop products and includes some marketed under common store brands. The FDA updated the list of eye drop products on Monday, Oct. 30, to include a brand sold by…
House Republicans propose $14.3 billion in aid to Israel, cut IRS funding: The Morning Rundown, Oct. 31, 2023
House Republicans unveil their plans to send aid to Israel with a bill cutting funding for the IRS. And have you purchased your Halloween candy yet? You might have some sticker shock when you do. These stories and more highlight The Morning Rundown for Tuesday, Oct. 31, 2023. House GOP unveils $14.3 billion Israel aid bill;…
Panera Bread has announced it is updating its warnings online and in-store concerning its caffeinated lemonade beverage. The change comes after a lawsuit was filed by the family of University of Pennsylvania student Sarah Katz last week. The suit alleged Katz, who had a heart condition, died after drinking Panera’s Charged Lemonade in September 2022.…
A Maine community comes together to heal just days after the state’s worst mass shooting. And Panera Bread adds warnings to a caffeinated drink after the death of an Ivy League student. These stories and more highlight The Morning Rundown for Monday, Oct. 30, 2023. Maine community mourns after mass shooting A town in Maine,…
President Biden speaks to the nation, telling Americans why it’s vital that Israel and Ukraine win their wars. And CVS announces it’s pulling popular brands of cold medicine from its store shelves. These stories and more highlight The Morning Rundown for Friday, Oct. 20, 2023. Biden: Israel, Ukraine victory is ‘vital for America’s national security’ In…
Welcome back to trustworthy journalism.
Here at Straight Arrow News, we…
Report without partisan spin, earning distinctions from media bias experts at AllSides and Ad Fontes
Share what other news outlets are underreporting with our Media Miss™ tool
Provide perspective with opinions and commentary from all sides